Crinetics Pharmaceuticals, Inc. (CRNX)

NASDAQ: CRNX · Real-Time Price · USD

29.50

-0.59 (-1.98%)

Aug 14, 2025, 11:37 AM - Market open

Crinetics Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Aug '25 Aug 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
Market Capitalization	2,778	4,742	2,377	985	1,340	465	Upgrade
Market Cap Growth	-23.72%	99.50%	141.36%	-26.50%	188.40%	-23.56%	Upgrade
Enterprise Value	1,687	3,932	1,874	620	1,151	283	Upgrade
Last Close Price	30.09	51.13	35.58	18.30	28.41	14.11	Upgrade
PS Ratio	2035.74	4563.69	592.26	207.88	1242.80	6542.73	Upgrade
PB Ratio	2.42	3.58	4.41	3.11	4.04	2.75	Upgrade
P/TBV Ratio	2.42	3.58	4.41	3.11	4.04	2.75	Upgrade
EV/Sales Ratio	1212.16	3783.97	467.04	130.82	1067.39	3982.45	Upgrade
Debt / Equity Ratio	0.04	0.04	0.10	0.01	0.01	0.03	Upgrade
Asset Turnover	0.00	0.00	0.01	0.01	0.00	0	Upgrade
Quick Ratio	17.49	22.83	12.92	12.17	20.96	16.47	Upgrade
Current Ratio	17.80	23.05	13.07	12.45	21.55	16.92	Upgrade
Return on Equity (ROE)	-36.94%	-32.02%	-50.16%	-50.57%	-42.98%	-51.61%	Upgrade
Return on Assets (ROA)	-23.77%	-20.46%	-28.18%	-29.84%	-25.19%	-29.85%	Upgrade
Return on Capital (ROIC)	-25.12%	-21.53%	-30.57%	-32.02%	-26.41%	-31.60%	Upgrade
Earnings Yield	-13.05%	-6.29%	-9.03%	-16.65%	-8.04%	-15.89%	Upgrade
FCF Yield	-10.79%	-4.85%	-7.20%	-11.87%	-6.64%	-13.39%	Upgrade
Buyback Yield / Dilution	-30.19%	-39.11%	-11.71%	-35.24%	-26.24%	-25.95%	Upgrade

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q